B&K

B&K Co., Ltd, a biopharmaceutical company specializing in protein drug development and headquartered in Qingdao, has filed for an initial public offering (IPO) on the Hong Kong Stock Exchange. The company’s IPO details, including pricing, have not yet been disclosed. Since its establishment in 2012, B&K has focused on research…